Patent details

92834 Product Name: Tédizolide, optionnellement sou s la forme d'un ester, en particulier un phosphate ou un sel de celui-ci pharmaceutiquement acceptable

Basic Information

Publication number:
92834
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP048084586
Legal Status:
Active
Application number:
92834
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/991 - phosphate de tédizolide
Marketing Authorization Type:
Marketing Authorization Date:
25/03/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
17/09/2015
First Marketing Authorization date:
25/03/2015
Grant date:
17/11/2015
Activation date:
17/12/2024
Publication date:
17/11/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
17/12/2029
SPC Extension Expiration:
17/12/2029
Rejection date:
Withdrawal date:

Owner

From:
17/09/2015
 
 

Name:
DONG-A ST CO. LTD.
Address:
64 CHEONHO-DAERO, DONGDAEMUN-GU, SEOUL, Korea (Republic) (KR)

Agent

Name:
KIRKPATRICK
From:
17/09/2015
Address:
AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)
To:

Inventor

1

Name:
LEE Tae Ho
Address:
Korea (Republic) (KR)

2

Name:
IM Weon Bin
Address:
Korea (Republic) (KR)

3

Name:
CHO Chong Hwan
Address:
Korea (Republic) (KR)

4

Name:
RHEE Jae Keol
Address:
Korea (Republic) (KR)

5

Name:
CHOI Sung Hak
Address:
Korea (Republic) (KR)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
22
Annual Fee Amount:
420 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/09/2024
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages